Nonmelanoma Skin Cancers - Who Is in the Waiting Room

Pearls on the current concepts in diagnosis and management of NMSC

Overview & Learning Objectives

• Review the burden of keratinocyte carcinomas (KCC)
• Recognize advances in risk stratification of patients with keratinocyte carcinoma
  
• Discuss recently approved therapeutic strategies in CSCC, including the use of Immune Checkpoint Inhibitors as primary treatment for advanced disease, as well as emerging strategies in the neo-adjuvant and adjuvant setting
  
• Review the recent evidence demonstrating activity of Immune Checkpoint Inhibitors for Basal Cell Carcinoma

This site represents our opinions only. See our full Disclaimer and Terms of Use Agreement